Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

• Główni autorzy: Anjay Rastogi (Autor), Ashté Collins (Autor), Ellie Kelepouris (Autor), Wayne Kotzker (Autor), John P. Middleton (Autor), Minesh Rajpal (Autor), Prabir Roy-Chaudhury (Autor), Glenn M. Chertow (Autor)
• Format: Książka
• Wydane: SAGE Publishing, 2024-08-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co-transporter-2 (SGLT2) inhibitor use in patients w...